Carvedilol Phosphate Capsule, Extended Release
Product Images NDC 69238-2579

Product Visual Gallery

This gallery contains 10 technical images submitted to the FDA as part of the official labeling for Carvedilol Phosphate (NDC 69238-2579). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Amneal Pharmaceuticals Ny Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Carvedilol Phosphate Extended Release Capsules 1)

Chemical structure of Carvedilol Phosphate showing its molecular components and arrangement including a phenyl group, ether linkages, and phosphate with ethanol solvation.*

FDA Label Image

80mg 30ct Label (Carvedilol Phosphate Extended Release Capsules 10)

Label for Carvedilol Phosphate Extended-Release Capsules, 80 mg strength, oral dosage form. The label indicates the product is for prescription use only, with a quantity of 30 capsules. Distributed by Amneal Pharmaceuticals LLC, Bridgewater, NJ. The label includes dosage storage instructions, safety warnings, and a barcode.*

FDA Label Image

Figure 1 Survival Analysis For Copernicus (intent-to-treat) (Carvedilol Phosphate Extended Release Capsules 2)

A line graph depicting percent mortality over time in months, comparing two groups: Placebo and Carvedilol. The y-axis shows % Mortality from 0 to 30, and the x-axis shows time from 0 to 21 months. The Carvedilol group shows consistently lower mortality than the Placebo group, with a noted P-value of 0.0014 indicating statistical significance.*

FDA Label Image

Figure 2 Effects On Mortality For Subgroups In Copernicus (Carvedilol Phosphate Extended Release Capsules 3)

A forest plot chart comparing subgroups of patients based on characteristics like gender, age, race, diabetic status, ischemic condition, heart rate, systolic blood pressure, and spironolactone use. Variables are plotted along a horizontal axis ranging from 0.0 to 2.0 with data points and confidence intervals for each subgroup, visualizing relative measures for all patients at the bottom.*

FDA Label Image

Figure 3 Survival Analysis For Capricorn (intent-to-treat) (Carvedilol Phosphate Extended Release Capsules 4)

A line graph comparing percentage mortality over 24 months between Carvedilol and Placebo groups. The vertical axis shows % Mortality from 0 to 30, and the horizontal axis shows time in months from 0 to 24. Two lines indicate mortality trends, with the Placebo group showing higher mortality than the Carvedilol group. A P value of 0.03 is indicated on the chart.*

FDA Label Image

Figure 4 Effects On Mortality For Subgroups In Capricorn (Carvedilol Phosphate Extended Release Capsules 5)

A forest plot chart displaying hazard ratios with confidence intervals for various patient subgroups, including age, sex, prior conditions, treatments, and clinical measures. The X-axis is labeled 'Hazard Ratio' ranging approximately from 0.4 to 1.3, with a reference line at 1. Subgroups such as age (<70, ≥70), sex (men, women), Killip class, and others related to myocardial infarction (MI) and heart conditions are listed on the Y-axis.*

FDA Label Image

Figure 5. Changes From Baseline In Systolic Blood Pressure And Diastolic Blood Pressure Measured By 24-hour Abpm (Carvedilol Phosphate Extended Release Capsules 6)

This image contains two line graphs showing the change in systolic blood pressure (SBP) and diastolic blood pressure (DBP) over 24 hours after a morning dose of carvedilol phosphate extended-release capsules at 20 mg, 40 mg, and 80 mg strengths. The graphs depict time in hours on the x-axis and blood pressure change in mmHg on the y-axis, with distinct lines for each dosage strength.*

FDA Label Image

10mg 30ct Label (Carvedilol Phosphate Extended Release Capsules 7)

Label for Carvedilol Phosphate Extended-Release Capsules, 10 mg strength, oral dosage form. The package contains 30 capsules and is labeled for once-a-day dosing with Rx only status. The product is distributed by Amneal Pharmaceuticals LLC, Bridgewater, NJ. The label includes storage instructions, warnings about the safety seal, and dosing guidance reference.*

FDA Label Image

20mg 30ct Label (Carvedilol Phosphate Extended Release Capsules 8)

Label for Carvedilol Phosphate Extended-Release Capsules 20 mg, oral dosage form by Amneal Pharmaceuticals NY LLC. The label indicates a pack of 30 capsules, with a red and orange capsule image. It includes storage instructions and warnings about dosage and packaging integrity.*

FDA Label Image

40mg 30ct Label (Carvedilol Phosphate Extended Release Capsules 9)

Carvedilol Phosphate Extended-Release Capsules 40 mg in a 30 count package by Amneal Pharmaceuticals LLC. The label highlights once-a-day dosing and includes a barcode, storage instructions (20° to 25°C), and safety warnings such as keeping medication out of reach of children and not using if the safety seal is broken.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.